Reuters logo
BRIEF-Abbvie and harpoon therapeutics announce immuno-oncology research collaboration
2017年10月18日 / 下午12点55分 / 1 个月前

BRIEF-Abbvie and harpoon therapeutics announce immuno-oncology research collaboration

Oct 18 (Reuters) - Abbvie Inc

* Abbvie and Harpoon Therapeutics announce immuno-oncology research collaboration

* Abbvie Inc - ‍financial terms were not disclosed.​

* Abbvie Inc - ‍under terms of agreement, Harpoon will engineer tritac molecules directed against selected cancer targets using its proprietary platform​

* Abbvie Inc says Harpoon will ‍provide Abbvie right to pursue further development and commercialization of the tritac molecules​

* Abbvie - collaboration to incorporate Harpoon’s tritac platform with co’s research-stage immuno-oncology targets to develop novel cancer therapeutics​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below